Related Experiment Video
Updated: Aug 7, 2026

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
Published on: October 14, 2016
Characteristics of chronic left ventricular dysfunction induced by coronary embolization in a canine model
A S Blaustein1, B D Hoit, L F Wexler
1Division of Cardiology, VA Medical Center and University of Cincinnati College of Medicine, OH 45267-0575, USA.
Insights
Chronic heart failure in dogs, induced by embolization, shows reduced coronary vasodilator reserve and impaired left ventricular function despite normal responses to certain drugs. This model mimics human heart failure syndromes.
Area of Science:
- Cardiovascular Science
- Heart Failure Research
- Animal Models of Disease
Background:
- Chronic heart failure (CHF) is a complex syndrome with significant morbidity and mortality.
- Understanding the pathophysiology of CHF is crucial for developing effective treatments.
- Animal models are essential for studying disease mechanisms and testing interventions.
Purpose of the Study:
- To characterize coronary vascular reserve, left ventricular function, and inotropic response in a canine model of chronic heart failure.
- To investigate the structural changes associated with chronic heart failure induced by embolization.
- To compare findings in the heart failure model with normal control dogs.
Main Methods:
- Induction of chronic heart failure in dogs via intracoronary embolization (EMB) with 50-micron spheres.
- Assessment of coronary vascular reserve, left ventricular (LV) function, and inotropic responses 12-39 months post-embolization.
- Histological analysis using light and electron microscopy to evaluate myocardial structure and fibrosis.
Main Results:
- Embolization led to sustained LV volume enlargement, increased wall thickness, reduced ejection fraction, and elevated end-diastolic pressures.
- Coronary vasodilator reserve was reduced in EMB dogs, despite increased coronary vascular volume.
- Histological analysis revealed diffuse fibrosis and a 14% loss of myocytes, disrupting myocardial architecture.
Conclusions:
- This canine model of chronic heart failure exhibits LV systolic dysfunction and elevated diastolic pressures, mirroring human conditions.
- The observed fibrosis and myocyte loss contribute to impaired cardiac function and reduced coronary vasodilator reserve.
- The model provides valuable insights into the pathophysiology of congestive heart failure and its structural basis.
Abstract:
We have characterized the coronary vascular reserve, left ventricular function and inotropic response in dogs with chronic heart failure consequent to intracoronary embolization (EMB) with 50 microns spheres. We conducted studies 12-39 months after embolization and contrasted the findings with normal (CON) dogs. Acute embolization produced sustained LV volume enlargement and increased wall thickness, reduction of LV ejection fraction and elevated end-diastolic pressures; resting catecholamine levels were also increased. Responses to phenylephrine, nitroprusside, and dobutamine were identical in CON and EMB and coronary vasodilator reserve was reduced despite larger coronary vascular volume. Analysis by light microscopy showed a diffuse focal and interstitial fibrosis distributed uniformly from endocardium to epicardium associated with 14% loss of myocytes. This created a functional separation of myocardial muscle bundles and a disruption of the syncytial nature of the heart. Electron microscopy of the areas of fibrosis revealed myocytes in states ranging from normal appearing, to ghosts with evidence of cytolysis and loss of the sarcolemma. This model of chronic congestive heart failure with LV systolic dysfunction and elevated LV diastolic pressures shares a number of features with the syndrome in humans.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
07:41Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022